Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies.
二型糖尿病中的鈉葡萄糖共同轉運蛋白2抑制劑:心臟衰竭臨床試驗效益在實際臨床實踐中有體現嗎?觀察性研究的系統性回顧和荟萃分析。
Diabetes Obes Metab 2023-01-31
'A Missed Therapeutic Opportunity? SGLT-2 Inhibitor Use in General Medicine Patients With Heart Failure: A Retrospective Audit of Admissions to a Tertiary Health Service'.
一個被忽略的治療機會?SGLT-2 抑制劑在一般醫學患者心臟衰竭中的應用:對三級保健服務入院患者的回顧性審計。
Clin Med Insights Cardiol 2022-11-05
The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospective cross-sectional study.
第二型糖尿病患者中鈉葡萄糖共同轉運蛋白2抑製劑和葡萄糖樣肽-1受體激動劑的處方模式:一項兩個中心的回顧性橫斷面研究。
Front Public Health 2023-01-27
Underprescription of SGLT2i and GLP-1 RA: CAREPRO-T2D (Cardiorenal Protection in Type 2 Diabetes) Cross-Sectional Study.
SGLT2i 和 GLP-1 RA 的低處方率:CAREPRO-T2D(2型糖尿病心腎保護)橫断面研究。
Cureus 2023-01-12
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs.
2型糖尿病、心臟衰竭和動脈粥樣硬化心血管疾病患者中SGLT2抑制劑的使用率:來自退伍軍人事務部的見解。
JACC Heart Fail 2023-08-27
[SGLT2 inhibitors : on the borders of diabetology, cardiology, nephrology and… primary care].
SGLT2抑制劑:處於糖尿病學、心臟病學、腎臟學和初級保健的邊界。
Rev Med Liege 2023-09-18
[GLP-1 receptor agonists in type 2 diabetes : paradoxical real-life underuse in patients with atherosclerotic cardiovascular disease].
GLP-1受體激動劑在2型糖尿病中的應用:對於具有動脈粥樣硬化心血管疾病的患者,現實生活中存在的悖論性低使用率。
Rev Med Liege 2024-03-19
Prescribing patterns of SGLT-2 inhibitors for patients with heart failure: A two-center analysis.
心衰患者 SGLT-2 抑制劑的處方模式:兩家醫療中心的分析。
Am Heart J Plus 2024-03-22
Update on evidence-based clinical application of sodium-glucose cotransporter inhibitors: Insight to uncommon cardiovascular disease scenarios in diabetes.
基於證據的鈉-葡萄糖共轉運蛋白抑制劑臨床應用更新:對糖尿病中不常見心血管疾病情境的洞察。
World J Diabetes 2024-08-05